[Characteristics of chemotherapy of pulmonary tuberculosis and its effectiveness in patients with diabetes mellitus]. 1991

M A Karachunskiĭ, and N V Adamovich, and A A Abdullaev

Assessment of tolerance to drug preparations and the effectiveness of this therapy in patients with tuberculosis and concurrent diabetes mellitus and with liver abnormality has shown a certain similarity between them, which consists in the fact that these patients were more often given non-conventional combinations of drugs than patients having no combined pathology. The initial regimen of chemotherapy was changed due to a poor tolerance of drug preparations. Prescription of Essentiale in this case to patients with pulmonary tuberculosis and diabetes mellitus is conducive to decline in severity of the adverse reactions to drugs and makes it possible to increase chemotherapy effectiveness.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M A Karachunskiĭ, and N V Adamovich, and A A Abdullaev
January 1999, Klinichna khirurhiia,
M A Karachunskiĭ, and N V Adamovich, and A A Abdullaev
September 1975, Vrachebnoe delo,
M A Karachunskiĭ, and N V Adamovich, and A A Abdullaev
January 2001, Respiration; international review of thoracic diseases,
M A Karachunskiĭ, and N V Adamovich, and A A Abdullaev
May 1972, Medicina interna,
M A Karachunskiĭ, and N V Adamovich, and A A Abdullaev
January 1975, Problemy tuberkuleza,
M A Karachunskiĭ, and N V Adamovich, and A A Abdullaev
January 1987, Problemy tuberkuleza,
M A Karachunskiĭ, and N V Adamovich, and A A Abdullaev
January 2004, Problemy tuberkuleza i boleznei legkikh,
M A Karachunskiĭ, and N V Adamovich, and A A Abdullaev
September 1990, Vrachebnoe delo,
M A Karachunskiĭ, and N V Adamovich, and A A Abdullaev
January 1979, Problemy tuberkuleza,
M A Karachunskiĭ, and N V Adamovich, and A A Abdullaev
January 1987, Terapevticheskii arkhiv,
Copied contents to your clipboard!